Heartlink Medical-B (02160.HK) released its interim results, with a net loss attributable to shareholders of 2.163 million yuan, a decrease of 96.17% year-on-year.

Zhitong Financial News App, Xintong Medical-B (02160.HK) released its interim performance for the six months ending June 30, 2025. The group achieved revenue of 229 million yuan, an increase of 2.67% year-on-year; the net loss attributable to equity shareholders of the company was 2.163 million yuan, a decrease of 96.17% year-on-year; basic loss per share was 0.09 cents.